081660:KRXMisto Holdings Corp. Analysis
Data as of 2026-06-02 - not real-time
₩37,550.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Misto Holdings is trading at 37,550 KRW, well below its 20‑day (38,522 KRW), 50‑day (40,417 KRW) and 200‑day (42,265 KRW) simple moving averages, indicating a bearish price environment. The 14‑day RSI sits at 39, suggesting the stock is approaching oversold conditions. MACD remains in bearish territory with the line (-902) under its signal (-898) and a negative histogram, confirming downward momentum. Daily volume has been tapering, reflected in the “decreasing” volume trend, which may limit short‑term buying pressure. Despite the technical weakness, the discounted cash‑flow model values the company at roughly 86,000 KRW, implying a potential upside of more than 50 % from current levels. The forward P/E of 7.1 and a dividend yield of 7.6 % (payout ratio 45 %) make the stock attractive from a value standpoint.
Operating margins of 15 % and a gross margin above 53 % demonstrate solid profitability, while revenue is growing modestly at 4.2 % YoY. However, the balance sheet is heavily leveraged, with debt‑to‑equity near 88 % and free cash flow turning negative, raising concerns about long‑term cash generation. The company’s beta of 0.49 points to lower systematic risk, yet 30‑day price volatility exceeds 32 %, indicating pronounced short‑term swings. The “Extreme Greed” sentiment index (92.8) reflects strong market appetite, which could further support price appreciation if sentiment persists. In this context, the stock appears fundamentally undervalued but technically challenged, suggesting a cautious buying approach. Investors should weigh the high dividend yield and upside against leverage and bearish momentum when deciding on exposure.
Operating margins of 15 % and a gross margin above 53 % demonstrate solid profitability, while revenue is growing modestly at 4.2 % YoY. However, the balance sheet is heavily leveraged, with debt‑to‑equity near 88 % and free cash flow turning negative, raising concerns about long‑term cash generation. The company’s beta of 0.49 points to lower systematic risk, yet 30‑day price volatility exceeds 32 %, indicating pronounced short‑term swings. The “Extreme Greed” sentiment index (92.8) reflects strong market appetite, which could further support price appreciation if sentiment persists. In this context, the stock appears fundamentally undervalued but technically challenged, suggesting a cautious buying approach. Investors should weigh the high dividend yield and upside against leverage and bearish momentum when deciding on exposure.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Oversold RSI indicating near‑term price support
- High dividend yield providing income cushion
- Price below key moving averages suggesting potential rebound
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF‑derived fair value showing >50% upside
- Attractive forward P/E and value orientation
- Stable operating margins despite cyclical sector
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Long‑term upside relative to fair value
- Consistent dividend policy with moderate payout ratio
- Brand licensing and diversified product mix supporting earnings
Key Metrics & Analysis
Financial Health
Revenue Growth4.20%
Profit Margin5.13%
P/E Ratio7.1
ROE12.62%
ROA5.23%
Debt/Equity87.69
Op. Cash Flow₩562.3B
Free Cash Flow₩-150128017408
Technical Analysis
TrendBearish
RSI39.3
Support₩36,000.00
Resistance₩41,600.00
MA 20₩38,522.50
MA 50₩40,417.00
MA 200₩42,264.75
MACDBearish
VolumeDecreasing
Fear & Greed Index92.77
Valuation
Fair Value₩85,956.61
Target Price₩57,583.33
Upside/Downside53.35%
GradeUndervalued
TypeValue
Dividend Yield7.59%
Risk Assessment
Beta0.49
Volatility32.27%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.